Daily Sepsis Research Analysis
Today's top sepsis papers span mechanistic immunology, neuroprotective preclinical therapy, and nationwide pediatric outcomes. A CD38–mTOR axis driving monocyte exhaustion and endothelial injury is identified, hydrogen inhalation rescues mitophagy via SIRT1 to protect against sepsis-associated encephalopathy, and Thai national data reveal high in-hospital and post-discharge mortality in pediatric septic shock with clear risk factors.
Summary
Today's top sepsis papers span mechanistic immunology, neuroprotective preclinical therapy, and nationwide pediatric outcomes. A CD38–mTOR axis driving monocyte exhaustion and endothelial injury is identified, hydrogen inhalation rescues mitophagy via SIRT1 to protect against sepsis-associated encephalopathy, and Thai national data reveal high in-hospital and post-discharge mortality in pediatric septic shock with clear risk factors.
Research Themes
- Immune exhaustion and endothelial dysfunction in sepsis
- Mitophagy and neuroprotection in sepsis-associated encephalopathy
- Population-level mortality and survivorship in pediatric septic shock
Selected Articles
1. Propagation of monocyte exhaustion memory and underlying mechanisms.
Using co-culture models, the authors show that LPS-induced exhausted monocytes transmit an exhaustion phenotype to naïve monocytes, induce endothelial apoptosis and adhesion molecule upregulation, and suppress T-cell proliferation. CD38 inhibition mitigates these effects, and mTOR signaling is implicated as a key regulator, positioning the CD38–mTOR axis as a therapeutic target in sepsis-related immune dysfunction.
Impact: This study provides mechanistic evidence for how monocyte exhaustion spreads and causes endothelial and T-cell dysfunction, highlighting CD38–mTOR as an actionable axis. It advances understanding of sepsis immunopathology and suggests specific targets for therapeutic intervention.
Clinical Implications: Targeting CD38 or mTOR could help reverse immunosuppression and vascular barrier injury in sepsis. While clinical translation requires in vivo validation, these pathways inform drug repurposing (e.g., CD38/mTOR inhibitors) and biomarker development.
Key Findings
- Exhausted monocytes induced by prolonged LPS propagate exhaustion to neighboring naïve monocytes.
- Exhausted monocytes trigger endothelial apoptosis, upregulate ICAM-1/VCAM-1, and enhance monocyte transmigration.
- CD38 inhibition mitigates endothelial injury and restores T-cell proliferation and activation.
- mTOR signaling regulates exhaustion propagation; its inhibition downregulates exhaustion markers and STAT1/STAT3/S6K signaling.
Methodological Strengths
- Multi-cell co-culture system integrating monocytes, endothelial cells, and T cells.
- Mechanistic mapping with pharmacologic inhibition of CD38 and mTOR and downstream signaling analyses.
Limitations
- In vitro models without in vivo validation limit generalizability to human sepsis.
- LPS-induced exhaustion may not fully recapitulate clinical pathogen- and host-driven heterogeneity.
Future Directions: Validate CD38–mTOR targeting in in vivo sepsis models and assess translational biomarkers of monocyte exhaustion and endothelial injury in patients.
Monocyte exhaustion is a dysfunctional state characterized by prolonged pathogenic inflammation and immune suppression, commonly observed in chronic infections and sepsis. However, the mechanisms underlying the generation and propagation of exhausted monocytes remain poorly understood. In this study, we investigate the impacts of exhausted monocytes on neighboring naïve monocytes, endothelial cells, and T cell function. Using an in vitro co-culture system, we demonstrate that exhausted monocytes induced by prolonged LPS stimulation propagate the exhaustion phenotype to neighboring naïve monocytes. Meanwhile these exhausted monocytes can promote endothelial apoptosis, upregulate adhesion molecules ICAM-1 and VCAM-1, and enhance monocyte transmigration, contributing to endothelial dysfunction. Pharmacological inhibition of CD38, a key marker of monocyte exhaustion, significantly mitigates these effects, highlighting its critical role in monocyte-driven endothelial alterations. Furthermore, we show that exhausted monocytes suppress T cell proliferation and activation, a process reversed by CD38 inhibition. We also identify mTOR signaling as a key regulator of monocyte exhaustion and its propagation, with mTOR inhibition partially restoring monocyte functionality by downregulating exhaustion markers and STAT1/STAT3/S6K signaling. Collectively, our findings highlight the CD38-mTOR axis as a central driver of monocyte exhaustion and its pathological consequences, offering potential therapeutic targets for reversing immune dysfunction in inflammatory diseases.
2. Molecular hydrogen-mediated SIRT1 activation alleviates sepsis-associated encephalopathy by promoting mitophagy.
In a murine CLP model of SAE, 2% hydrogen inhalation improved 7-day survival and cognition, upregulated SIRT1, and restored PINK1/Parkin-mediated mitophagy. Reduced STING phosphorylation and inflammatory cytokines, and reversal by the SIRT1 inhibitor EX527, support a SIRT1–mitophagy mechanism of neuroprotection.
Impact: This work links hydrogen therapy to SIRT1-driven mitophagy restoration, providing a mechanistic basis for neuroprotection in SAE and a plausible translational target.
Clinical Implications: If validated in humans, low-concentration hydrogen inhalation or SIRT1 modulation could be explored as adjunctive therapy for sepsis-associated encephalopathy, with biomarkers of mitophagy guiding patient selection.
Key Findings
- 2% hydrogen inhalation increased 7-day survival from 50% to 75% (P<0.01) and improved Morris water maze performance.
- Hydrogen upregulated SIRT1 and promoted PINK1/Parkin-mediated mitophagy, reducing STING phosphorylation and pro-inflammatory cytokines.
- SIRT1 inhibition with EX527 reversed hydrogen’s protective effects, confirming SIRT1 dependence.
Methodological Strengths
- Comprehensive multimodal assessment (behavior, histology, proteomics, EM, immunoblotting).
- Pharmacologic loss-of-function (EX527) to test causal SIRT1 involvement.
Limitations
- Preclinical murine model; human translatability and optimal dosing/timing remain unknown.
- Randomization/blinding and sample size details are not reported in the abstract.
Future Directions: Conduct randomized preclinical and early-phase clinical trials to evaluate safety, dosing, and efficacy of hydrogen inhalation in SAE with mitophagy biomarkers.
BACKGROUND: Sepsis-associated encephalopathy (SAE) constitutes a major determinant of sepsis-related mortality across acute and survivorship phases. While molecular hydrogen (H₂) exhibits neuroprotective capacities in SAE, its precise mechanistic underpinnings remain unresolved. This study investigates the protection of SAE by H METHODS: SAE was modeled in mice via cecal ligation and puncture (CLP). The cognitive abilities of mice were evaluated via behavioral tests (Morris water maze), observation of the pathological morphology of brain tissues (HE staining), and observation of neuronal cell structure (Nissl staining). Proteomics was employed to explore the specific mechanism by which hydrogen regulates mitophagy. Western blotting, immunofluorescence, and electron microscopy were used to quantify the dynamic changes of sirtuin 1 (SIRT1) and mitophagy during SAE. In addition, an SIRT1 inhibitor (EX527) was utilized to observe its effects on hydrogen treatment and mitophagy. RESULTS: Inhalation of 2% hydrogen significantly enhanced the 7-day survival rate of septic mice (from 50 to 75%, P < 0.01) and improved cognitive performance in the Morris water maze, as evidenced by increased platform crossings (P < 0.05) and reduced escape latency. Hydrogen treatment upregulated SIRT1 expression and promoted PINK1/Parkin-mediated mitophagy, leading to reduced phosphorylation of STING, decreased levels of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α), and suppressed neuronal apoptosis in the hippocampal CA1 region. These protective effects were reversed by the SIRT1 inhibitor EX527. CONCLUSIONS: This study demonstrates that inhalation of 2% H2 exerts significant protective effects against SAE, in which SIRT1 plays a pivotal role by modulating PINK1-dependent mitophagy, thereby ameliorating neuroinflammation and neuronal apoptosis. By rescuing mitophagy deficits, SIRT1 targeting merits clinical exploration for SAE. TRIAL REGISTRATION: Not applicable.
3. Factors associated with mortality in pediatric septic shock in Thai children with long-term survival analysis post-hospital discharge: a nationwide study 2015-2022.
In a nationwide Thai cohort of 18,697 pediatric septic shock cases, in-hospital mortality was 28.7%, with acute respiratory failure (aOR 15.51) and malignancy (aOR 2.43) strongly associated with death. Among survivors, 16.2% died post-discharge, particularly preschool-aged children and those with neoplasms (aHR 4.56), underscoring the need for targeted acute care and structured survivorship follow-up.
Impact: Provides contemporary, population-level mortality and survivorship data from an LMIC, identifying high-yield targets for intervention in pediatric septic shock.
Clinical Implications: Prioritize rapid, guideline-concordant resuscitation for children with respiratory failure and malignancy; implement post-ICU survivorship programs focusing on preschoolers and oncology patients to reduce post-discharge mortality.
Key Findings
- Nationwide in-hospital mortality was 28.7% among 18,697 Thai children with septic shock.
- Acute respiratory failure was the strongest in-hospital mortality factor (aOR 15.51, 95% CI 13.24–18.16).
- Malignancy was a major comorbidity associated with death (aOR 2.43, 95% CI 2.12–2.78).
- Among 13,322 survivors, 16.2% died post-discharge; risk was highest in preschoolers and those with neoplasms (aHR 4.56, 95% CI 4.05–5.13).
Methodological Strengths
- Large, nationwide cohort with comprehensive coverage over 8 years.
- Multivariable regression and survival analyses distinguishing in-hospital vs. post-discharge mortality risks.
Limitations
- Retrospective design with potential misclassification and limited clinical granularity (e.g., severity scores, treatments).
- Follow-up duration details are heterogeneous and not precisely specified at the patient level.
Future Directions: Prospective registries capturing severity, therapies, and standardized post-discharge follow-up to evaluate targeted interventions in high-risk pediatric subgroups.
Septic shock remains a leading cause of preventable childhood death, yet contemporary population‑level data on early and post‑discharge outcomes in low‑ and middle‑income settings are scarce. We analyzed nationwide trends and risk factors for in‑hospital and long‑term mortality among Thai children with septic shock. This was a retrospective national study encompassing 18,697 children aged 1 month to under 18 years old hospitalized with septic shock in Thailand from January 2015 to December 2022. In-hospital mortality occurred in 5,375 children (28.7%). Acute respiratory failure was the strongest factor associated with in-hospital death (aOR 15.51, 95% CI 13.24-18.16; p < 0.001). Additionally, neoplasm was the most potent co-morbidity associated with mortality (aOR 2.43, 95% CI 2.12-2.78; p < 0.001). Of 13,322 hospital survivors, 2,155 (16.2%) died during follow‑up. Post‑discharge mortality was highest in preschool children and was also associated with neoplasms (aHR 4.56, 95% CI 4.05-5.13; p < 0.001). Nationwide data show that more than one in four Thai children with septic shock die in hospital, and one in eight additional deaths occur after discharge. Respiratory failure and malignant disease markedly heighten risk. Timely, guideline-concordant resuscitation, proactive management of high-risk comorbidities, and structured post-ICU follow-up are urgent priorities to improve both early and long-term survival.